Sentence examples for mortality in solid from inspiring English sources

Infections remain a major cause of morbidity and mortality in solid organ transplant recipients.

Posttransplant lymphoproliferative disorders (PTLDs) are an uncommon but important cause of morbidity and mortality in solid organ transplant recipients.

Most importantly, metastasis is responsible for 90% of mortality in solid tumors.

Infection with carbapenem-resistant Acinetobacter baumannii has been associated with high morbidity and mortality in solid organ transplant recipients.

It is also unknown whether and if so to what degree parasitic infections contribute to mortality in solid organ recipients worldwide.

More recent investigation has demonstrated that the endothelium plays a central role in chronic rejection, where inappropriate activation of endothelial cells results in obliterative vasculopathy and accelerated post-transplant atherosclerosis [ 10], a major cause of morbidity and mortality in solid organ transplant recipients.

CsA exerts additional effects on non-immune cell populations and may adversely effect microvascular endothelial cells, contributing to chronic rejection, a long-term clinical complication and significant cause of mortality in solid-organ transplants, including patients with small bowel allografts.

Despite advances in antifungal regimens in terms of prophylaxis and treatment, IFIs may lead to high mortality rates in solid organ recipients.

Cancer metastasis is one of the leading causes of mortality in patients with solid tumors [1].

These results suggest SAPS II and APACHE II as a good predictor of in-hospital sepsis-related mortality in patients with solid tumours and haematological patients, respectively.

Conclusions: This study highlights ECOG as a predictor of in-hospital sepsis-related mortality in patients with solid tumours and raises the awareness around the search of oncological baseline characteristics that may be determinants of sepsis-related mortality.